Kazia Therapeutics Limited American Depositary Shares (KZIA) is a publicly traded Healthcare sector company. As of May 21, 2026, KZIA trades at $12.96 with a market cap of $143.52M and a P/E ratio of 0.00. KZIA moved +7.41% today. Year to date, KZIA is +126.75%; over the trailing twelve months it is +266.38%. Its 52-week range spans $2.86 to $39.05. Analyst consensus is buy with an average price target of $25.00. Rallies surfaces KZIA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
1 analysts cover KZIA: 0 strong buy, 1 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $25.00.
| Metric | Value |
|---|---|
| Price | $12.96 |
| Market Cap | $143.52M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $39.05 |
| 52-Week Low | $2.86 |
| Volume | 8 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover KZIA: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $25.00.